Jaguar Health, Inc.
(NASDAQ : JAGX)

( )
JAGX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.79%200.371.9%$442.26m
TEVATeva Pharmaceutical Industries Ltd. -1.51%8.512.0%$79.68m
RDYDr. Reddy's Laboratories Ltd. -2.73%59.762.0%$5.53m
TXMDTherapeuticsMD, Inc. -7.79%0.3114.2%$2.38m
JAGXJaguar Health, Inc. -6.53%0.812.6%$1.70m
TAROTaro Pharmaceutical Industries Ltd. -1.98%46.636.6%$0.99m
ABEOAbeona Therapeutics, Inc. -8.44%0.232.5%$0.88m
COCPCocrystal Pharma, Inc. -6.31%0.520.0%$0.44m
LFVNLifeVantage Corp. -5.18%6.043.6%$0.28m
CPHIChina Pharma Holdings, Inc. -3.75%0.390.1%$0.11m

Company Profile

Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of gastrointestinal products. The firm focuses on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. It operates through the Human Health and Animal Health segments. The Human Health segment manufactures human products and the ongoing advertising of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The Animal Health segment commercializes prescription and non-prescription products for companion and production animals. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.